F19.95 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder

Name of the Condition

• Other Psychoactive Substance Use, Unspecified with Psychoactive Substance-Induced Psychotic Disorder
• ICD-10 Code: F19.95

Summary

This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and a psychotic disorder is present. It is classified as "unspecified" when the exact agent is unknown or not documented, and "with psychoactive substance-induced psychotic disorder" indicates the presence of psychotic symptoms directly resulting from substance use.

Causes

The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. Psychotic symptoms arise when the substance’s effects disrupt normal brain function, leading to delusions, hallucinations, or disorganized thinking.

Risk Factors

• Peer pressure or cultural acceptance of substance use.
• Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
• Availability of and access to psychoactive substances.
• History of substance use disorders or prior psychotic episodes.

Symptoms

Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. Psychotic-specific symptoms can include delusions, hallucinations, disorganized speech, or catatonia. The exact presentation depends on the unidentified psychoactive agent.

Diagnosis

Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. A psychotic disorder is confirmed when symptoms persist beyond intoxication or withdrawal and are directly linked to substance use.

Treatment Options

• Medication: Antipsychotics may be used to manage acute psychotic symptoms.
• Counseling and Behavioral Therapies: Aim to address substance use and prevent relapse.
• Supportive Care: Monitoring for safety and stabilization of symptoms.

Prognosis and Follow-Up

Prognosis depends on the severity of substance use and psychotic symptoms, as well as adherence to treatment. Regular follow-up is essential to monitor for relapse, manage symptoms, and adjust treatment plans. Long-term recovery may require ongoing support.

Complications

• Worsening of psychotic symptoms or substance use.
• Increased risk of self-harm or harm to others.
• Social or occupational impairment due to persistent symptoms.

Lifestyle & Prevention

• Avoiding known psychoactive substances.
• Seeking early intervention for substance use or mental health concerns.
• Building a support network to reduce stress and triggers.

When to Seek Professional Help

Seek help if psychotic symptoms (e.g., delusions, hallucinations) or substance use interfere with daily functioning, or if there is a risk of harm to self or others.

Tips for Medical Coders

Document the presence of a substance-induced psychotic disorder and the unspecified nature of the psychoactive substance. Ensure clinical notes support the diagnosis and specify any relevant substance use history or symptoms.